Altimmune Inc
NASDAQ:ALT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Altimmune Inc
NASDAQ:ALT
|
US |
|
Reservoir Media Inc
NASDAQ:RSVR
|
US |
|
F
|
FendX Technologies Inc
CNSX:FNDX
|
CA |
|
Fulgent Genetics Inc
NASDAQ:FLGT
|
US |
|
G
|
Gemtek Technology Co Ltd
TWSE:4906
|
TW |
|
Bain Capital Specialty Finance Inc
NYSE:BCSF
|
US |
|
AltEnergy Acquisition Corp
OTC:AEAE
|
US |
|
U
|
U-Tech Co Ltd
KOSDAQ:178780
|
KR |
|
C
|
Cathay General Bancorp
NASDAQ:CATY
|
US |
|
A
|
Amgen Inc
DUS:AMG
|
US |
|
Abundance International Ltd
SGX:541
|
SG |
|
S
|
Smart Equity AG
XHAM:SE3
|
DE |
|
C
|
Carry Wealth Holdings Ltd
HKEX:643
|
HK |
|
I
|
Intuitive Surgical Inc
F:IUI1
|
US |
|
K
|
K&K Superstore Southern PCL
SET:KK
|
TH |
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
UK |
|
Byd Electronic (International) Co Ltd
OTC:BYDIY
|
CN |
|
A
|
AGCO Corp
F:AGJ
|
US |
Bankruptcy Probability
Altimmune Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Altimmune Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Altimmune Inc
NASDAQ:ALT
|
635.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
454.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
178.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
47.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Altimmune Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Altimmune Inc has total debt of 34.7m USD. This includes both short-term (0 USD) and long-term (34.7m USD) debt.
You can find a full breakdown on its Balance Sheet.